Literature DB >> 11722648

Rat mast cell protease-I enhances immunoglobulin E production by mouse B cells stimulated with interleukin-4.

T Yoshikawa1, T Imada, H Nakakubo, N Nakamura, K Naito.   

Abstract

Mast cell chymase plays important roles in inflammation and tissue remodeling. Here we show that mast cell chymase also functions as an enhancer of immunoglobulin production. In the culture of murine spleen cells stimulated with lipopolysaccharide and interleukin-4, purified rat chymase (rat mast cell protease-I; RMCP-I), at physiological concentrations, enhanced immunoglobulin E (IgE) and IgG1 syntheses but not IgG3 synthesis. The enhancement was also evident when spleen cells depleted of T cells and macrophages were employed as responding cells. Enzymatic activity of RMCP-I was required to enhance IgE and IgG1, because two inhibitors for chymotryptic enzymes, chymostatin and Y-40613, a novel chymase inhibitor, suppressed the enhanced immunoglobulin production, and phenylmethylsulphonyl fluoride, an irreversible inhibitor for serine proteases, totally abolished the enhancing effect. Furthermore, a specific inhibitor for Zn2+-dependent metalloproteases, GI 129471, could also completely inhibit the production of IgE and IgG1 that was enhanced by RMCP-I, suggesting that a metalloprotease also played an essential role in the immunoglobulin production. Our results together with others show that proteases from mast cell granules have important function not only in the efferent phase but also in the afferent phase of immune responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722648      PMCID: PMC1783305          DOI: 10.1046/j.1365-2567.2001.01320.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  51 in total

1.  Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart.

Authors:  H Urata; A Kinoshita; K S Misono; F M Bumpus; A Husain
Journal:  J Biol Chem       Date:  1990-12-25       Impact factor: 5.157

2.  Purification of murine suppressive factor of allergy into distinct CD23-modulating and IgE-suppressive proteins.

Authors:  S Matsushita; J F Marcelletti; L R Katz; D H Katz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  Selective inhibition of antigen presentation to cloned T cells by protease inhibitors.

Authors:  J Puri; Y Factorovich
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

4.  Two types of human mast cells that have distinct neutral protease compositions.

Authors:  A A Irani; N M Schechter; S S Craig; G DeBlois; L B Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 5.  Regulation of IgE synthesis.

Authors:  K Ishizaka
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

6.  Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes.

Authors:  D Skokos; S Le Panse; I Villa; J C Rousselle; R Peronet; B David; A Namane; S Mécheri
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

7.  Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines.

Authors:  P Romagnani; A De Paulis; C Beltrame; F Annunziato; V Dente; E Maggi; S Romagnani; G Marone
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

8.  Activation of rat serosal mast cells by chymase, an endogenous secretory granule protease.

Authors:  B Schick; K F Austen; L B Schwartz
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

9.  Modulation of the biologic activities of IgE-binding factor. IV. Identification of glycosylation-enhancing factor as a kallikrein-like enzyme.

Authors:  M Iwata; J J Munoz; K Ishizaka
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

10.  Mast cell chymase. A potent secretagogue for airway gland serous cells.

Authors:  C P Sommerhoff; G H Caughey; W E Finkbeiner; S C Lazarus; C B Basbaum; J A Nadel
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

View more
  6 in total

1.  A novel (TG)n(GA)m repeat polymorphism 254 bp downstream of the mast cell chymase (CMA1) gene is associated with atopic asthma and total serum IgE levels.

Authors:  Shilpy Sharma; U Mabali Rajan; Amrendra Kumar; Abha Soni; Balaram Ghosh
Journal:  J Hum Genet       Date:  2005-05-28       Impact factor: 3.172

Review 2.  Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases.

Authors:  Yanwen Qin; Guo-Ping Shi
Journal:  Pharmacol Ther       Date:  2011-05-12       Impact factor: 12.310

3.  Association between SNP rs1800875, serum chymase and immunoglobulin E levels in patients with coronary heart disease.

Authors:  Chun-Na Jin; Hong Ma; Yan Lin; Jian-An Wang; Mei-Xiang Xiang
Journal:  J Zhejiang Univ Sci B       Date:  2011-08       Impact factor: 3.066

Review 4.  Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases.

Authors:  Aina He; Guo-Ping Shi
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

5.  The Inclusion of a Supercritical Fluid Extract, Obtained From Honey Bee Pollen, in the Diet of Gilthead Sea Bream (Sparus aurata), Improves Fish Immune Response by Enhancing Anti-oxidant, and Anti-bacterial Activities.

Authors:  Concetta Maria Messina; Valentina Panettieri; Rosaria Arena; Giuseppe Renda; Cristobal Espinosa Ruiz; Maria Morghese; Giovanni Piccolo; Andrea Santulli; Fulvia Bovera
Journal:  Front Vet Sci       Date:  2020-02-25

Review 6.  Mast Cell Modulation of B Cell Responses: An Under-Appreciated Partnership in Host Defence.

Authors:  Alejandro M Palma; Mark R Hanes; Jean S Marshall
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.